⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL78411 | 1.00 | — | — | |
| SCHEMBL745540 | 1.00 | — | — | |
| SCHEMBL10421518 | 1.00 | — | — | |
| SCHEMBL2932486 | 0.87 | — | — | |
| SCHEMBL2772735 | 0.87 | — | — | |
| SCHEMBL9318497 | 0.87 | — | — | |
| SCHEMBL9566452 | 0.87 | — | — | |
| SCHEMBL10421254 | 0.87 | — | — | |
| SCHEMBL271315 | 0.87 | — | — | |
| SCHEMBL7064892 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024062043-A1 | SUBSTITUTED PHENOTHIAZINES AS FERROPTOSIS INHIBITORS | UNIVERSITEIT ANTWERPEN (BE) | 2024-03-28 | — | — | WO | claimed |
| US-20220213048-A1 | (R)-(2-METHYLOXIRAN-2-YL)METHYL 4-BROMOBENZENESULFONATE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-07-07 | — | — | US | claimed |
| WO-2020223267-A1 | (R)-(2-METHYLOXIRAN-2-YL)METHYL 4-BROMOBENZENESULFONATE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2020-11-05 | — | — | WO | claimed |
| US-9211300-B2 | 4′-fluoro nucleosides for the treatment of HCV | IDENIX PHARMACEUTICALS LLC (US) | 2015-12-15 | — | — | US | claimed |
| US-20120172378-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2012-07-05 | — | — | US | claimed |
| US-8153669-B2 | Quaternary ammonium salts as M3 antagonists | NOVARTIS AG (CH) | 2012-04-10 | — | — | US | claimed |
| EP-1686119-B1 | Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors | SMITHKLINE BEECHAM PLC (GB) | 2009-07-29 | — | — | EP | claimed |
| US-20090170877-A1 | 5,6-Trimethylenepyrimidin-4-one compounds | SMITHKLINE BEECHAM P.L.C. | 2009-07-02 | — | — | US | claimed |
| EP-1686119-A1 | PYRIMIDINE-4-ONE DERIVATIVES AS LDL-PLA2 INHIBITORS | SMITHKLINE BEECHAM PLC (GB) | 2006-08-02 | — | — | EP | claimed |
| US-20040097525-A1 | For therapy of atheroscelerosis | SMITHKLINE BEECHAM PLC | 2004-05-20 | — | — | US | claimed |
| US-20040023984-A1 | Compounds for the treatment of alzheimer's disease | BONNIE DAVIS | 2004-02-05 | — | — | US | claimed |
| EP-1263740-A1 | PYRIMIDINE-4-ONE DERIVATIVES AS LDL-PLA2 INHIBITORS | SmithKline Beecham plc (GB) | 2002-12-11 | — | — | EP | claimed |
| US-20020103213-A1 | Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-08-01 | — | — | US | claimed |
| WO-2001060805-A1 | PYRIMIDINE-4-ONE DERIVATIVES AS LDL-PLA2 INHIBITORS | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-08-23 | — | — | WO | claimed |
| JP-2755403-B2 | — | — | 1998-05-20 | — | — | JP | claimed |
| EP-0231622-B1 | Inhibition of the 5-lipoxygenase pathway | SMITHKLINE BEECHAM CORP (US) | 1994-08-24 | — | — | EP | claimed |
| EP-0363415-A4 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | — | 1993-03-17 | — | — | EP | claimed |
| EP-0363415-A1 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Davis, Bonnie (US) | 1990-04-18 | — | — | EP | claimed |
| WO-1988008708-A1 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | BONNIE DAVIS (US) | 1988-11-17 | — | — | WO | claimed |
| US-11958818-B2 | (R)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-04-16 | — | — | US | disclosed |
| US-11958818-B2 | (R)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-04-16 | — | — | US | disclosed |
| US-11945778-B2 | C4-carbonothioate-substituted tryptamine derivatives and methods of using | Enveric Biosciences Canada Inc. (CA) | 2024-04-02 | — | — | US | disclosed |
| US-RE49851-E1 | Pyridinylaminopyrimidine derivatives, preparation process and use thereof | SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. (CN) | 2024-02-27 | — | — | US | disclosed |
| US-11845726-B2 | C4-carbonothioate-substituted tryptamine derivatives and methods of using | Enveric Biosciences Canada Inc. (CA) | 2023-12-19 | — | — | US | disclosed |
| US-20230321040-A1 | C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-10-12 | — | — | US | disclosed |
| US-20230295085-A1 | C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-09-21 | — | — | US | disclosed |
| WO-2023173229-A1 | SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-09-21 | — | — | WO | disclosed |
| WO-2023173197-A1 | C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-09-21 | — | — | WO | disclosed |
| WO-2023173227-A1 | C4-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-09-21 | — | — | WO | disclosed |
| US-11707447-B1 | C4-carbonothioate-substituted tryptamine derivatives and methods of using | Enveric Biosciences Canada Inc. (CA) | 2023-07-25 | — | — | US | disclosed |
| US-20220213048-A1 | (R)-(2-METHYLOXIRAN-2-YL)METHYL 4-BROMOBENZENESULFONATE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-07-07 | — | — | US | disclosed |
| US-20220213048-A1 | (R)-(2-METHYLOXIRAN-2-YL)METHYL 4-BROMOBENZENESULFONATE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-07-07 | — | — | US | disclosed |
| US-11219627-B2 | Clearance of amyloid beta | SYNAPTEC DEVELOPMENT LLC (US) | 2022-01-11 | — | — | US | disclosed |
| US-RE48687-E1 | Pyridinylaminopyrimidine derivatives, preparation process and use thereof | SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. (CN) | 2021-08-17 | — | — | US | disclosed |
| EP-3181560-B1 | PYRIDINE AMIDOPYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | SHANGHAI ALLIST PHARMACEUTICALS CO LTD (CN) | 2020-11-25 | — | — | EP | disclosed |
| WO-2020223267-A1 | (R)-(2-METHYLOXIRAN-2-YL)METHYL 4-BROMOBENZENESULFONATE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2020-11-05 | — | — | WO | disclosed |
| WO-2020223267-A1 | (R)-(2-METHYLOXIRAN-2-YL)METHYL 4-BROMOBENZENESULFONATE | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2020-11-05 | — | — | WO | disclosed |
| US-10072002-B2 | Pyridinylaminopyrimidine derivatives, preparation process and use thereof | SHANGHAI ALLIST PHARMACEUTICALS, INC. (CN) | 2018-09-11 | — | — | US | disclosed |
| EP-3212620-A1 | PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF | Jubilant Generics Limited (Formerly Jubilant Life Sciences Division) (IN) | 2017-09-06 | — | — | EP | disclosed |
| US-20170210739-A1 | PYRIDINYLAMINOPYRIMIDINE DERIVATIVES, PREPARATION PROCESS AND USE THEREOF | SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. (CN) | 2017-07-27 | — | — | US | disclosed |
| EP-3181560-A1 | PYRIDINE AMIDOPYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | Shanghai Allist Pharmaceuticals, Inc. (CN) | 2017-06-21 | — | — | EP | disclosed |
| EP-3142669-A2 | CLEARANCE OF AMYLOID ß | Synaptec Development LLC (US) | 2017-03-22 | — | — | EP | disclosed |
| WO-2016067308-A1 | PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF | JUBILANT GENERICS LIMITED (FORMERLY JUBILANT LIFE SCIENCES DIVISION) (IN) | 2016-05-06 | — | — | WO | disclosed |
| US-9266841-B2 | Compounds | GLAXO GROUP LIMITED (GB) | 2016-02-23 | — | — | US | disclosed |
| US-20150328230-A1 | CLEARANCE OF AMYLOID BETA | SYNAPTEC DEVELOPMENT LLC (US) | 2015-11-19 | — | — | US | disclosed |
| WO-2015176069-A2 | CLEARANCE OF AMYLOID ß | SYNAPTEC DEVELOPMENT LLC (US) | 2015-11-19 | — | — | WO | disclosed |
| US-20150045375-A1 | NOVEL COMPOUNDS | GLAXO GROUP LTD (GB) | 2015-02-12 | — | — | US | disclosed |
| US-8871775-B2 | Compounds | GLAXO GROUP LIMITED (GB) | 2014-10-28 | — | — | US | disclosed |
| US-20120263646-A1 | IMAGING AGENTS AND THEIR USE FOR THE DIAGNOSTIC IN VIVO OF NEURODEGENERATIVE DISEASES, NOTABLY ALZHEIMER'S DISEASE AND DERIVATIVE DISEASES | GUERBET (FR) | 2012-10-18 | — | — | US | disclosed |
| EP-2501696-A2 | IMAGING AGENTS AND THEIR USE FOR THE DIAGNOSTIC IN VIVO OF NEURODEGENERATIVE DISEASES, NOTABLY ALZHEIMER'S DISEASE AND DERIVATIVE DISEASES | Guerbet (FR) | 2012-09-26 | — | — | EP | disclosed |
| US-20120172378-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2012-07-05 | — | — | US | disclosed |
| EP-2445881-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | General Electric Company (US) | 2012-05-02 | — | — | EP | disclosed |
| US-20110294853-A1 | Bis Aromatic Compounds for Use in the Treatment of Inflammation | BIOLIPOX AB (SE) | 2011-12-01 | — | — | US | disclosed |
| WO-2011045415-A2 | NEW IMAGING AGENTS AND THEIR USE FOR THE DIAGNOSTIC IN VIVO OF NEURODEGENERATIVE DISEASES, NOTABLY ALZHEIMER'S DISEASE AND DERIVATIVE DISEASES | GUERBET (FR) | 2011-04-21 | — | — | WO | disclosed |
| US-7928091-B2 | Cathepsin cysteine protease inhibitors | MERCK FROSST CANADA LTD. (CA) | 2011-04-19 | — | — | US | disclosed |
| WO-2010151389-A1 | PROCESS FOR MAKING ORGANIC COMPOUNDS AND THE ORGANIC COMPOUNDS MADE THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2010-12-29 | — | — | WO | disclosed |
| EP-2066674-B1 | OCTAHYDROPYRROLO [3, 4-C] PYRROLE DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS | HOFFMANN LA ROCHE (CH) | 2010-06-30 | — | — | EP | disclosed |
| US-20100144765-A1 | 5,6-TRIMETHYLENEPYRIMIDIN-4-ONE COMPOUNDS | HICKEY DEIDRE MARY BERNADETTE | 2010-06-10 | — | — | US | disclosed |
| WO-2010029300-A1 | BIS AROMATIC COMPOUNDS FOR USE IN THE TREATMENT OF INFLAMMATION | BIOLIPOX AB (SE) | 2010-03-18 | — | — | WO | disclosed |
| US-7652019-B2 | Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase | SMITHKLINE BEECHAM PLC (GB) | 2010-01-26 | — | — | US | disclosed |
| US-7638520-B2 | platelet activating factor aceylhydrolase inhibitors such as 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5-ethylpyrimidin-4-one; for treatment of atherosclerosis | SMITHKLINE BEECHAM, PLC (GB) | 2009-12-29 | — | — | US | disclosed |
| US-7625905-B2 | Octahydro-pyrrolo[3,4-c]pyrrole CCR5 receptor antagonists | ROCHE PALO ALTO LLC (US) | 2009-12-01 | — | — | US | disclosed |
| EP-1798252-B1 | CROSSLINKED FLUOROCOPOLYMER MOLDINGS | UNIMATEC CO LTD (JP) | 2009-10-21 | — | — | EP | disclosed |
| EP-1686119-B1 | Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors | SMITHKLINE BEECHAM PLC (GB) | 2009-07-29 | — | — | EP | disclosed |
| US-20090170877-A1 | 5,6-Trimethylenepyrimidin-4-one compounds | SMITHKLINE BEECHAM P.L.C. | 2009-07-02 | — | — | US | disclosed |
| EP-2066674-A1 | OCTAHYDROPYRROLO [3, 4-C] PYRROLE DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS | F.HOFFMANN-LA ROCHE AG (CH) | 2009-06-10 | — | — | EP | disclosed |
| US-20090118313-A1 | Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase | SMITHKLINE BEECHAM P.L.C. | 2009-05-07 | — | — | US | disclosed |
| US-20090093444-A1 | Cathepsin Cysteine Protease Inhibitors | MERCK FROSST CANADA LTD. (CA) | 2009-04-09 | — | — | US | disclosed |
| US-20090023863-A1 | CROSS-LINKED FLUORINE-CONTAINING COPOLYMER MOLDINGS | UNIMATEC CO., LTD. (JP) | 2009-01-22 | — | — | US | disclosed |
| US-7470694-B2 | Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase | SMITHKLINE BEECHAM, PLC (GB) | 2008-12-30 | — | — | US | disclosed |
| US-20080103125-A1 | Heterocylic antiviral compounds | ROCHE PALO ALTO LLC | 2008-05-01 | — | — | US | disclosed |
| WO-2008034731-A1 | OCTAHYDROPYRROLO [3, 4-C] PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-03-27 | — | — | WO | disclosed |
| EP-1902031-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | Merck Frosst Canada Ltd. (CA) | 2008-03-26 | — | — | EP | disclosed |
| US-20070155762-A1 | Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase | SMITHKLINE BEECHAM PLC | 2007-07-05 | — | — | US | disclosed |
| EP-1798252-A1 | CROSSLINKED FLUOROCOPOLYMER MOLDINGS | Unimatec Co., Ltd. (JP) | 2007-06-20 | — | — | EP | disclosed |
| US-20070123549-A1 | platelet activating factor aceylhydrolase inhibitors such as 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5-ethylpyrimidin-4-one; for treatment of atherosclerosis | SMITHKLINE BEECHAM PLC | 2007-05-31 | — | — | US | disclosed |
| EP-1476509-B1 | SELF-POLISHING ANTIFOULING PAINT | JOTUN AS (NO) | 2007-04-11 | — | — | EP | disclosed |
| WO-2007003056-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2007-01-11 | — | — | WO | disclosed |
| US-7153861-B2 | For therapy of atheroscelerosis | SMITHKLINE BEECHAM P.L.C. (GB) | 2006-12-26 | — | — | US | disclosed |
| EP-1686119-A1 | PYRIMIDINE-4-ONE DERIVATIVES AS LDL-PLA2 INHIBITORS | SMITHKLINE BEECHAM PLC (GB) | 2006-08-02 | — | — | EP | disclosed |
| EP-1263740-B1 | PYRIMIDINE-4-ONE DERIVATIVE AS LDL-PLA2 INHIBITOR | SMITHKLINE BEECHAM PLC (GB) | 2006-07-19 | — | — | EP | disclosed |
| US-20060003376-A1 | Non-destructive quality control method for microarray substrate coatings via labeled doping | CONZONE SAMUEL D | 2006-01-05 | — | — | US | disclosed |
| US-20050064209-A1 | Low-fluorescent, chemically durable hydrophobic patterned substrates for the attachment of biomolecules | HAINES DANIEL (US) | 2005-03-24 | — | — | US | disclosed |
| EP-1084109-B1 | 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NITRIC OXIDE SYNTHASE INHIBITORS | PFIZER PROD INC (US) | 2005-01-26 | — | — | EP | disclosed |
| WO-2005000760-A2 | NON-DESTRUCTIVE QUALITY CONTROL METHOD FOR MICROARRAY SUBSTRATE COATINGS VIA LABELED DOPING | SCHOTT AG (DE) | 2005-01-06 | — | — | WO | disclosed |
| US-20040258927-A1 | Non-destructive quality control method for microarray substrate coatings via labeled doping | SCHOTT AG (DE) | 2004-12-23 | — | — | US | disclosed |
| EP-1476509-A2 | SELF-POLISHING ANTIFOULING PAINT | Jotun AS (NO) | 2004-11-17 | — | — | EP | disclosed |
| EP-0760657-B9 | NOVEL POTENT INDUCERS OF TERMINAL DIFFERENTIATION AND METHODS OF USE THEREOF | SLOAN KETTERING INSTITUTEFOR C (US) | 2004-08-11 | — | — | EP | disclosed |
| US-20040097525-A1 | For therapy of atheroscelerosis | SMITHKLINE BEECHAM PLC | 2004-05-20 | — | — | US | disclosed |
| US-20040023984-A1 | Compounds for the treatment of alzheimer's disease | BONNIE DAVIS | 2004-02-05 | — | — | US | disclosed |
| US-6649619-B1 | 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl) benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimeth ylenepyrimidin-4-one or salt; lipoprotein-associated phospholipase A inhibitors | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-11-18 | — | — | US | disclosed |
| EP-0760657-B1 | NOVEL POTENT INDUCERS OF TERMINAL DIFFERENTIATION AND METHODS OF USE THEREOF | SLOAN KETTERING INSTITUTEFOR C (US) | 2003-11-12 | — | — | EP | disclosed |
| WO-2003070832-A2 | SELF-POLISHING ANTIFOULING PAINT | JOTUN AS (NO) | 2003-08-28 | — | — | WO | disclosed |
| US-6569848-B1 | Analogs of galanthamine; cholinesterase inhibitors | Davis, Bonnie | 2003-05-27 | — | — | US | disclosed |
| US-6555682-B1 | S-triazines substituted by 1,3,5-tri(7-benzothiazol-2-yl or 7-diphenylamino fluoren-2-yl dericatives; absorption cross-sections; lasers; fluorescent dyes | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2003-04-29 | — | — | US | disclosed |
| EP-1263740-A1 | PYRIMIDINE-4-ONE DERIVATIVES AS LDL-PLA2 INHIBITORS | SmithKline Beecham plc (GB) | 2002-12-11 | — | — | EP | disclosed |
| US-20020103213-A1 | Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-08-01 | — | — | US | disclosed |
| US-6319919-B1 | INHIBITING ACETYL CHOLINESTERASE ACTIVITY | Davis, Bonnie | 2001-11-20 | — | — | US | disclosed |
| WO-2001060805-A1 | PYRIMIDINE-4-ONE DERIVATIVES AS LDL-PLA2 INHIBITORS | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-08-23 | — | — | WO | disclosed |
| US-6268358-B1 | Compounds for the treatment of Alzheimer's disease | Davis, Bonnie | 2001-07-31 | — | — | US | disclosed |
| US-6160053-A | Flourine-containing copolymer composition | NIPPON MEDTRON, LIMITED (JP) | 2000-12-12 | — | — | US | disclosed |
| US-6150485-A | COPOLYMERIZATION OF VINYLIDENE FLUORIDE, TETRAFLUOROETHYLENE, PERFLUOROALKYL VINYL ETHER AND CHLOROTRIFLUOROETHYLENE POLYMERS IN THE PRESENCE OF IODINE AND BROMINE | NIPPON MEKTRON, LIMITED (JP) | 2000-11-21 | — | — | US | disclosed |
| US-6124404-A | COPOLYMERIZING TWO MONOMERS FROM THE GROUP CONTAINING A FLUORINATED MONOMERS AND PROPYLENE IN PRESENCE OF SATURATED IODO OR IODOBROMO HYDROCARBON, THEN GRAFT COPOLYMERIZING WITH TETRAFLOROETHYLENE AND POLYFLUOROVINYL ETHER | NIPPON MEKTRON LIMITED (JP) | 2000-09-26 | — | — | US | disclosed |
| US-6103819-A | BLENDING A VINYL CONTAINING ORGANOPOLYSILOXANE WITH A STABILIZER HINDERED PHENOLS, CURING AND POST-BAKING FOR FORMING A SAFE BABY BOTTLE NIPPLE | GENERAL ELECTRIC COMPANY (US) | 2000-08-15 | — | — | US | disclosed |
| EP-0834521-B1 | Fluoroelastomer and its cross-linkable composition | NIPPON MEKTRON KK (JP) | 2000-03-22 | — | — | EP | disclosed |
| US-6011129-A | COPOLYMERIZATION OF VINYLIDENE FLUORIDE, TETRAFLUOROETHYLENE, PERFLUOROALKYL VINYL ETHER AND CHLOROTRIFLUOROETHYLENE IN THE PRESENCE OF A BROMINE CONTAINING MONOMER COMPOUND AND AN IODINE AND BROMINE CONTAINING COMPOUND | NIPPON MEKTRON, LIMITED (JP) | 2000-01-04 | — | — | US | disclosed |
| US-5969066-A | TERPOLYMER CONTAINING TETRAFLUOROETHYLENE, PERFLUOROALKYL VINYL ETHER, VINYLIDENE FLUORIDE CROSSLINKED BY A PEROXIDE, LOW TEMPERATURE PROPERTIES, SOLVENT AND CHEMICAL RESISTANCE | NIPPON MEKTRON, LIMITED (JP) | 1999-10-19 | — | — | US | disclosed |
| US-5959025-A | NONTOXIC SILICONE RUBBER COMPRISING MIXTURE OF ADDITION-CURED VINYLORGANOPOLYSILOXANE, FILLER, AND A STERICALLY HINDERED PHENOL STABILIZER; BABY BOTTLE NIPPLES | GENERAL ELECTRIC COMPANY (US) | 1999-09-28 | — | — | US | disclosed |
| US-5910552-A | ELASTOMER COMPRISING TETRAFLUOROETHYLENE, PERFLUOROALKYL PEFLUOROVINYL ETHER, BROMINE-CONTAINING UNSATURATED COMPOUND | NIPPON MEKTRON, LIMITED (JP) | 1999-06-08 | — | — | US | disclosed |
| US-5902868-A | A FLUOROPOLYMERIC ELASTOMER CONTAINING TETRAFLUOROETHYLENE MONOMER A PERFLUOROVINYL ETHER AND A BROMINE CONTAINING UNSATURATED MONOMER, A POLYFUNCTIONAL UNSATURATED COMPOUND AS COCROSSLINKER AND AN ORGANIC PEROXIDE | NIPPON MEKTRON, LIMITED (JP) | 1999-05-11 | — | — | US | disclosed |
| US-5891974-A | BLEND CONTAINING AN UNSATURATED BROMINE COMPOUND; HEAT, CHEMICAL RESISTANCE | NIPPON MEKTRON, LIMITED (JP) | 1999-04-06 | — | — | US | disclosed |
| EP-0891995-A1 | Process for producing fluorine-containing elastomer | Nippon Mektron, Limited (JP) | 1999-01-20 | — | — | EP | disclosed |
| US-5739373-A | Optically active phosphono analogs of succinates and synthesis thereof | MONSANTO COMPANY (US) | 1998-04-14 | — | — | US | disclosed |
| EP-0834521-A1 | Fluoroelastomer and its cross-linkable composition | NIPPON MEKTRON, LTD. (JP) | 1998-04-08 | — | — | EP | disclosed |
| US-5543457-A | SILICONE ARTICLE CONTAINING NITROSAMINE FORMATION INHIBITING AMOUNT OF HINDERED PHENOL | GENERAL ELECTRIC COMPANY (US) | 1996-08-06 | — | — | US | disclosed |
| US-5314893-A | Antiviral tetrahydropyrans | BRISTOL-MYERS SQUIBB CO. (US) | 1994-05-24 | — | — | US | disclosed |
| US-5225504-A | Perfluoroalkylene-perfluoroalkyl vinyl ether copolymer | NOK CORPORATION (JP) | 1993-07-06 | — | — | US | disclosed |
| EP-0363415-A4 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | — | 1993-03-17 | — | — | EP | disclosed |
| EP-0208855-B1 | PROCESS FOR PREPARING PIPERIDYLIDENE DIHYDRODIBENZO(A,D)CYCLOHEPTENES AND AZA DERIVATIVES THEREOF, COMPOUNDS OBTAINED BY SUCH PROCESS AND THE USE OF SUCH COMPOUNDS FOR PREPARING USEFUL PHARMACEUTICAL COMPOSITIONS | SCHERING CORPORATION (US) | 1991-03-06 | — | — | EP | disclosed |
| US-4985582-A | CHEMICAL INTERMEDIATES FOR BICYCLIC RING COMPOUNDS HAVING MULTIPLE SULFUR ATOMS IN THE RING SYSTEM | THE WELLCOME FOUNDATION LTD. (GB) | 1991-01-15 | — | — | US | disclosed |
| US-4943622-A | Bromine and iodine containing hydrocarbon | NIPPON MEKTRON, LIMITED (JP) | 1990-07-24 | — | — | US | disclosed |
| EP-0363415-A1 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Davis, Bonnie (US) | 1990-04-18 | — | — | EP | disclosed |
| WO-1988008708-A1 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | BONNIE DAVIS (US) | 1988-11-17 | — | — | WO | disclosed |
| US-4748223-A | Process for producing peroxide-vulcanizable, fluorine-containing elastomer | NIPPON MEKTRON LIMITED (JP) | 1988-05-31 | — | — | US | disclosed |
| EP-0216625-A2 | Pesticidal compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1987-04-01 | — | — | EP | disclosed |
| EP-0208855-A1 | Process for preparing piperidylidene dihydrodibenzo(a,d)cycloheptenes and aza derivatives thereof, compounds obtained by such process and the use of such compounds for preparing useful pharmaceutical compositions | SCHERING CORPORATION (US) | 1987-01-21 | — | — | EP | disclosed |
| US-4575547-A | MELT PROCESSABILITY AND ANISOTROPY | POLAROID CORPORATION (US) | 1986-03-11 | — | — | US | disclosed |
| EP-0119494-A1 | Urease inhibited urea based fertilizer compositions containing phosphorus compounds | ALLIED CORPORATION (US) | 1984-09-26 | — | — | EP | disclosed |
| EP-0119494-A1 | Urease inhibited urea based fertilizer compositions containing phosphorus compounds | ALLIED CORPORATION (US) | 1984-09-26 | — | — | EP | disclosed |